跳至主要内容
临床试验/CTRI/2025/04/084358
CTRI/2025/04/084358尚未招募4 期

A comparative clinical study to evaluate the effect of Shadushan Guggulu and Triphala kwath in the management of Medoroga w.s.r. to Dyslipidemia

Prof Dr Vijay Chaudhary1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年6月20日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
To reduce the level of S.Cholesterol level below 200mg/dl

研究概览

简要总结

At the end of the trial, collected data will be analyzed by using appropriate statistical methods and will be present in the form of thesis.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
30.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Patients with Serum lipid profile : Serum Cholesterol- 200 to 350 mg/dl Serum Triglycerides.
  • 150 to 350 mg/dl Serum LDL.
  • 100 to 200 mg/dl Serum VLDL.
  • 30 to 100 mg/dl Serum HDL.
  • 20 to 40 mg/dl Patients willing to participate in the trial. Patients between the age group of 30-70 years of either gender will be selected for the study.

排除标准

  • Patient having major illness like Type-II Diabetes mellitus, Carcinoma, advanced Renal and Liver disorders.
  • Pregnant females and lactating mother.
  • Patients who has completed participation in any other clinical trial during the past 6 months.

结局指标

主要结局

To reduce the level of S.Cholesterol level below 200mg/dl

时间窗: 3 months

S.Triglycerides level below 150mg/dl

时间窗: 3 months

S.LDL level below 100mg/dl

时间窗: 3 months

次要结局

  • To assess the clinical safety of Shadushan Guggulu and Triphala Kwath in patients of Medoroga w.s.r. to Dyslipidaemia.(3 months)

研究者

发起方
Prof Dr Vijay Chaudhary
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验